Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Treosulfan

EU orphan designation number: EU/3/04/186   
Active ingredient: Treosulfan
Indication: Conditioning treatment prior to haematopoietic progenitor cell transplantation
Sponsor: medac Gesellschaft für klinische Spezialpräparate mbH
Fehlandtstraße 3, D-20354 Hamburg, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/02/2004 Centralised Orphan - Designation EMEA/OD/075/03 (2004)625 of 23/02/2004